Morgan Stanley Investment Management Ltd. disclosed in a filing on December 31, 2019 that it reduced its stake in Abbott Laboratories
Feb 20, 2020
Institutional Holdings Changes
MSIML is an active manager which performs bottom-up fundamental research to analyze the industries and companies in which they invest. Research and investment ideas are generated by the London-based Research Cooperative which fosters both intra- and inter-team communications through regular meetings. Their investment strategies span the risk/return spectrum across geographies, investment styles and asset classes, including equity, fixed income, alternatives and private markets. MSIML's portfolio management teams have ultimate responsibility for constructing portfolios. The team structure maximizes each team member's contribution to the investment process, while ensuring that a senior investor is always accountable for final decisions. Research is conducted by dedicated teams specializing in a particular niche of the fixed income market. The research teams use in-depth fundamental analysis, complemented by quantitative tools, to generate bottom-up investment ideas and are responsible for security selection.
In The News
Morgan Stanley Investment Management Ltd. disclosed in a filing on March 31, 2020 that it reduced its stake in Procter & Gamble Co.
Jun 04, 2020 - RelSci
May 27, 2020 - Business Wire